| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |